Just Other Articles

In the first article (first in a three part series) we explained the little known science of Axiology, the Value Profile and how it is helping CEO's obtain the greatest leverage from employee's strengths.

We d

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

escribed how a CEO (we called him Richard) can accurately measure and compare candidates for a specific position or work on a specific project.

In this article we continue on to discover additional and deeper

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

critical distinctions the Value Profile provides Richard to aid him in his decision to select the best candidate.

The insights revealed in the fourth section of the report provide Richard with an in depth unde

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

rstanding of a candidate's abilities for planning and organizing. People can keep working on a project until they get it right, or they can plan and get organized before they start.

Not everyone has the abilit

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

y to determine what is required to accomplish a project and have it completed on time. Some people have difficulty with directions they have been given or taking on responsibility for a project.

Richard does

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

not have time to "wait and see" if a person will be able to complete the project. He wants to know in advance whether or not the candidate has the ability to logically plan and organize a strategy and carry it ou

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

t. Using the Value Profile, Richard eliminates the gut-wrenching process of trying to determine who would be best to work on a crucial project. The Value Profile provides him with a roadmap.

A person's ability

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

to set realistic goals, implement plans and achieve them within a certain time frame can be determined and calculated. The results are plotted on a chart so Richard can see at a glance exactly which candidate exc

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

els in this area.

Richard has at his fingertips vital information about a person's ability to keep focused on the planning details and activities needed to reach the desired outcome. It is one thing to plan an

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

d organize, it's another to be self motivated to take action.

Right now, stop and think about your key people. Can they set realistic goals? Are they reaching those goals within a specified time frame? Is it i

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

mportant to you and the company for your key people to take action right away? Isn't it crucial for you to know which people have these capabilities?

Wouldn't you want to be certain your key people have a driv

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

e to stay on course despite obstacles and regardless of circumstances?

Let's get back to Richard. Now he knows which candidates can plan. Then, he can check the report to find out the attitudes of the differen

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

t candidates and their level of commitment to the company.

Companies are becoming more aggressive in attracting top talent. Richard wants to know how his key people feel about the company. He wants to reduce

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

the risk of handing someone a project, then finding out after the fact that the person does not have the drive or desire for the project, loyalty or commitment company.

Richard has started to narrow down his l

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

st of candidates as he looks to the future of the company. Which of the candidates has the capacity to become a manager? Who could take a long-term role and excel at leadership?

A unique aspect of the Value Pr

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ofile is that it provides Richard with accurate assessment of a person's intuitive insight or "gut feeling" about issues. More and more, executives are admitting they use and rely on their "gut feelings" to make

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

important decisions. Using intuitive insight, leaders are becoming more proficient at distinguishing which opportunities are best and which to avoid.

Top people are looking for challenging, meaningful and rewa

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

rding work. They seek positions where they use their talent and make a difference. They look forward to creating new opportunities for their company. These are the kind of candidates Richard searches for.

Othe

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

r important considerations when considering candidates for a specific project are stress factors, sources of motivation and communicating with others.

We will share insights on these three areas in the third a

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

rticle of this series.

(c) 2004, Team Results Inc. and Axelrod & Associates All rights in all media reserved. Right to publish this article is granted provided the article and the by-line are reprinted intact.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/5238/justotherarticles-How-CEOs-Can-Use-Axiology-To-Improve-The-Bottom-Line-Part-2.html">How CEO's Can Use Axiology To Improve The Bottom Line (Part 2)</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/5238/justotherarticles-How-CEOs-Can-Use-Axiology-To-Improve-The-Bottom-Line-Part-2.html]How CEO's Can Use Axiology To Improve The Bottom Line (Part 2)[/url]

The credit card is preferred by most people when paying for purchases and services because of its safety, security and ease of use. The use of credit cards is growing exponentially fueled by the growth of e-commerce and the increasing usage of credit cards in business-to-business transactions...

Starting Online Business is only the first step in the battle. Sure it is a good idea to start an Internet marketing campaign if members of your target audience are likely to use the Internet to research or purchase the products you sell or the services you offer but these marketing efforts may turn out to be a complete waste of time if you are not diligent about evaluating the response to your Internet marketing. This means each time you implement a change to your marketing strategy; you should evaluate the results of the change to determine whether or not it generated a greater profit for you. This is important because it can help you determine what is working and what is not working for you.

The future is serious business and if your customers reach your future before you, they will leave you behind.

Tags

Links

Just Other Articles - How CEO's Can Use Axiology To Improve The Bottom Line (Part 2)

Related Articles: